The sodium iodide symporter (NIS): Regulation and approaches to targeting for cancer therapeutics

Pharmacology and Therapeutics

Volumn 135, Issue 3, 2012, Pages 355-370

  Kogai, Takahiko ^a   Brent, Gregory A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Posttranslational regulation; Sodium iodide symporter; Thyroid cancer; Transcriptional regulation

Indexed keywords

ALITRETINOIN; BETA INTERFERON; BUTYRIC ACID; CARBAMAZEPINE; DENDRITIC CELL VACCINE; DEXAMETHASONE; DNA VACCINE; DOXORUBICIN; HISTONE DEACETYLASE INHIBITOR; HYDROCORTISONE; IODIDE; IODINE 131; ISOBUTYLMETHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ONCOLYTIC VIRUS; PANOBINOSTAT; PERIFOSINE; RDEA 119; RETINOIC ACID; ROMIDEPSIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SODIUM IODIDE SYMPORTER; TAMIBAROTENE; TAZAROTENE; THEOPHYLLINE; TRICHOSTATIN A; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORINOSTAT;

ADD ON THERAPY; ANAPLASTIC THYROID CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER GENE THERAPY; CANCER RADIOTHERAPY; COLON CANCER; COLORECTAL CANCER; DIFFERENTIATED THYROID CANCER; DRUG EFFICACY; DRUG POTENTIATION; DRUG TARGETING; ENZYME INHIBITION; EXTERNAL BEAM RADIOTHERAPY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GLIOMA; HUMAN; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; MELANOMA; MESOTHELIOMA; MOLECULARLY TARGETED THERAPY; MULTIPLE MYELOMA; NEUROBLASTOMA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NUTRITIONAL REQUIREMENT; PANCREAS CANCER; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REGULATOR GENE; REGULATORY MECHANISM; THYROID CANCER; THYROID GLAND; THYROID MEDULLARY CARCINOMA; TRANSCRIPTION REGULATION; TUMOR ABLATION; UTERINE CERVIX CANCER; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 84864467278     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.06.007     Document Type: Review

References (208)

1. S.J. Ahn, Y.H. Jeon, Y.J. Lee, Y.L. Lee, S.W. Lee, and B.C. Ahn Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model Cancer Gene Ther 17 2010 492 500
2. C. Alexander, J.B. Bader, A. Schaefer, C. Finke, and C.M. Kirsch Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma J Nucl Med 39 1998 1551 1554
3. H. Alotaibi, E. Yaman, D. Salvatore, V. Di Dato, P. Telkoparan, and R. Di Lauro Intronic elements in the Na+/I- symporter gene (NIS) interact with retinoic acid receptors and mediate initiation of transcription Nucleic Acids Res 38 2010 3172 3185
4. Y. Alsayed, S. Uddin, N. Mahmud, F. Lekmine, D.V. Kalvakolanu, and S. Minucci Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid J Biol Chem 276 2001 4012 4019
5. A. Altorjay, O. Dohan, A. Szilagyi, M. Paroder, I.L. Wapnir, and N. Carrasco Expression of the Na+/I- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus BMC Cancer 7 2007 5
6. F. Arturi, E. Ferretti, I. Presta, T. Mattei, A. Scipioni, and D. Scarpelli Regulation of iodide uptake and sodium/iodide symporter expression in the MCF-7 human breast cancer cell line J Clin Endocrinol Metab 90 2005 2321 2326
7. V.A. Beardmore, H.J. Hinton, C. Eftychi, M. Apostolaki, M. Armaka, and J. Darragh Generation and characterization of p38beta (MAPK11) gene-targeted mice Mol Cell Biol 25 2005 10454 10464
8. K. Boelaert, and J.A. Franklyn Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers? Lancet 361 2003 796 797
9. K. Boelaert, V.E. Smith, A.L. Stratford, T. Kogai, L.A. Tannahill, and J.C. Watkinson PTTG and PBF repress the human sodium iodide symporter Oncogene 26 2007 4344 4356
10. A. Boland, M. Ricard, P. Opolon, J.M. Bidart, P. Yeh, and S. Filetti Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy Cancer Res 60 2000 3484 3492
11. J.S. Bonifacino, and L.M. Traub Signals for sorting of transmembrane proteins to endosomes and lysosomes Annu Rev Biochem 72 2003 395 447
12. E.H. Bosch, H. van Doorne, and S. de Vries The lactoperoxidase system: the influence of iodide and the chemical and antimicrobial stability over the period of about 18 months J Appl Microbiol 89 2000 215 224
13. N.S. Bricker, and C.J. Hlad Jr. Observations on the mechanism of the renal clearance of I131 J Clin Invest 34 1955 1057 1072
14. K. Brown-Grant Extrathyroidal iodide concentrating mechanisms Physiol Rev 41 1961 189 213
15. H. Burgi, T.H. Schaffner, and J.P. Seiler The toxicology of iodate: a review of the literature Thyroid 11 2001 449 456
16. X. Cao, F. Kambe, L.C. Moeller, S. Refetoff, and H. Seo Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts Mol Endocrinol 19 2005 102 112
17. S.K. Carlson, K.L. Classic, E.M. Hadac, D. Dingli, C.E. Bender, and B.J. Kemp Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene AJR Am J Roentgenol 192 2009 279 287
18. M.R. Castro, E.R. Bergert, J.R. Goellner, I.D. Hay, and J.C. Morris Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake J Clin Endocrinol Metab 86 2001 5627 5632
19. R.R. Cavalieri Iodine metabolism and thyroid physiology: current concepts Thyroid 7 1997 177 181
20. H. Chen, and M.R. Juchau Recombinant human glutathione S-transferases catalyse enzymic isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro Biochem J 336 Pt 1 1998 223 226
21. S.J. Cheong, D. Jang, H.J. Jeong, S.T. Lim, M.H. Sohn, and J.A. Katzenellenbogen Reduction of stimulated sodium iodide symporter expression by estrogen receptor ligands in breast cancer cells Nucl Med Biol 38 2011 287 294
22. D.S. Chien, R.B. Sandri, and D.S. Tang-Liu Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats Drug Metab Dispos 20 1992 211 217
23. J.Y. Cho, R. Leveille, R. Kao, B. Rousset, A.F. Parlow, and W.E. Burak Jr. Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands J Clin Endocrinol Metab 85 2000 2936 2943
24. J.T. Chun, V. Di Dato, B. D'Andrea, M. Zannini, and R. Di Lauro The CRE-like element inside the 5′-upstream region of the rat sodium/iodide symporter gene interacts with diverse classes of b-Zip molecules that regulate transcriptional activities through strong synergy with Pax-8 Mol Endocrinol 18 2004 2817 2829
25. B.A. Conley, T.S. Ramsland, D.L. Sentz, S. Wu, D.M. Rosen, and M. Wollman Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice Cancer Chemother Pharmacol 43 1999 183 197
26. E. Costamagna, B. Garcia, and P. Santisteban The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene J Biol Chem 279 2004 3439 3446
27. G. Dai, O. Levy, and N. Carrasco Cloning and characterization of the thyroid iodide transporter Nature 379 1996 458 460
28. R.M. Day, Y.H. Lee, A.M. Park, and Y.J. Suzuki Retinoic acid inhibits airway smooth muscle cell migration Am J Respir Cell Mol Biol 34 2006 695 703
29. F.D. de Carvalho, and M. Quick Surprising substrate versatility in SLC5A6: Na+-coupled I- transport by the human Na+/multivitamin transporter (hSMVT) J Biol Chem 286 2011 131 137
30. E.C. de Souza, A.S. Padron, W.M. Braga, B.M. de Andrade, M. Vaisman, and L.E. Nasciutti MTOR downregulates iodide uptake in thyrocytes J Endocrinol 206 2010 113 120
31. H. de The, M.M. Vivanco-Ruiz, P. Tiollais, H. Stunnenberg, and A. Dejean Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene Nature 343 1990 177 180
32. G. De Vita, M. Zannini, A.M. Cirafici, R.M. Melillo, R. Di Lauro, and A. Fusco Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors Cell Growth Differ 9 1998 97 103
33. S.V. del Rincon, C. Rousseau, R. Samanta, and W.H. Miller Jr. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway Oncogene 22 2003 3353 3360
34. D. Dingli, K.W. Peng, M.E. Harvey, P.R. Greipp, M.K. O'Connor, and R. Cattaneo Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter Blood 103 2004 1641 1646
35. O. Dohan, Z. Baloch, Z. Banrevi, V. Livolsi, and N. Carrasco Rapid communication: predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases J Clin Endocrinol Metab 86 2001 2697 2700
36. O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, and M. Reed The sodium/iodide symporter (NIS): characterization, regulation, and medical significance Endocr Rev 24 2003 48 77
37. O. Dohan, A. De la Vieja, and N. Carrasco Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells Mol Endocrinol 20 2006 1121 1137
38. C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, and J.P. Travagli Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab 91 2006 2892 2899
39. R.M. Dwyer, S.M. Schatz, E.R. Bergert, R.M. Myers, M.E. Harvey, and K.L. Classic A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer Mol Ther 12 2005 835 841
40. R.M. Dwyer, E.R. Bergert, M.K. O'Connor, S.J. Gendler, and J.C. Morris Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors Hum Gene Ther 17 2006 661 668
41. D. Fabbro, C. Di Loreto, C.A. Beltrami, A. Belfiore, R. Di Lauro, and G. Damante Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms Cancer Res 54 1994 4744 4749
42. J.A. Fagin Challenging dogma in thyroid cancer molecular genetics - role of RET/PTC and BRAF in tumor initiation J Clin Endocrinol Metab 89 2004 4264 4266
43. M.S. Fenton, K.M. Marion, and J.M. Hershman Identification of cyclic adenosine 3′,5′-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer Endocrinology 149 2008 2592 2606
44. M.S. Fenton, K.M. Marion, A.K. Salem, R. Hogen, F. Naeim, and J.M. Hershman Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary thyroid cancer Thyroid 20 2010 965 974
45. J.B. Field, P.R. Larsen, K. Yamashita, K. Mashiter, and A. Dekker Demonstration of iodide transport defect but normal iodide organification in nonfunctioning nodules of human thyroid glands J Clin Invest 52 1973 2404 2410
46. N. Fortunati, M.G. Catalano, F. Marano, V. Mugoni, M. Pugliese, and O. Bosco The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS) Breast Cancer Res Treat 124 2010 667 675
47. L. Fozzatti, M.L. Velez, A.M. Lucero, J.P. Nicola, I.D. Mascanfroni, and D.R. Maccio Endogenous thyrocyte-produced nitric oxide inhibits iodide uptake and thyroid-specific gene expression in FRTL-5 thyroid cells J Endocrinol 192 2007 627 637
48. S.R. Frankel, A. Eardley, G. Heller, E. Berman, W.H. Miller Jr., and E. Dmitrovsky All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study Ann Intern Med 120 1994 278 286
49. E. Frohlich, P. Brossart, and R. Wahl Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines Eur J Nucl Med Mol Imaging 36 2009 780 790
50. T.W. Furlanetto, L.Q. Nguyen, and J.L. Jameson Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells Endocrinology 140 1999 5705 5711
51. F. Furuya, H. Shimura, H. Suzuki, K. Taki, K. Ohta, and K. Haraguchi Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin Endocrinology 145 2004 2865 2875
52. F. Furuya, J.A. Hanover, and S.Y. Cheng Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor Proc Natl Acad Sci U S A 103 2006 1780 1785
53. B. Garcia, and P. Santisteban PI3K is involved in the IGF-I inhibition of TSH-induced sodium/iodide symporter gene expression Mol Endocrinol 16 2002 342 352
54. A.C. Gerard, C. Daumerie, C. Mestdagh, S. Gohy, C. De Burbure, and S. Costagliola Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas J Clin Endocrinol Metab 88 2003 4977 4983
55. A. Goel, S.K. Carlson, K.L. Classic, S. Greiner, S. Naik, and A.T. Power Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene Blood 110 2007 2342 2350
56. J. Grimwood, L.A. Gordon, A. Olsen, A. Terry, J. Schmutz, and J. Lamerdin The DNA sequence and biology of human chromosome 19 Nature 428 2004 529 535
57. T. Hakkarainen, M. Rajecki, M. Sarparanta, M. Tenhunen, A.J. Airaksinen, and R.A. Desmond Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter Clin Cancer Res 15 2009 5396 5403
58. O.P. Hamnvik, P.R. Larsen, and E. Marqusee Thyroid dysfunction from antineoplastic agents J Natl Cancer Inst 103 2011 1572 1587
59. S. Han, J.D. Ritzenthaler, B. Wingerd, and J. Roman Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta J Biol Chem 280 2005 33240 33249
60. N. Harii, T. Endo, M. Ohmori, and T. Onaya Extracellular adenosine increases Na+/I- symporter gene expression in rat thyroid FRTL-5 cells Mol Cell Endocrinol 157 1999 31 39
61. N. Harii, C.J. Lewis, V. Vasko, K. McCall, U. Benavides-Peralta, and X. Sun Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis Mol Endocrinol 19 2005 1231 1250
62. B.R. Haugen, F. Pacini, C. Reiners, M. Schlumberger, P.W. Ladenson, and S.I. Sherman A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer J Clin Endocrinol Metab 84 1999 3877 3885
63. J. Herve, A.S. Cunha, B. Liu, Y. Valogne, M. Longuet, and R. Boisgard Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine- pancreas gene as a liver tumor-specific promoter Hum Gene Ther 19 2008 915 926
64. M. Hingorani, C. Spitzweg, G. Vassaux, K. Newbold, A. Melcher, and H. Pandha The biology of the sodium iodide symporter and its potential for targeted gene delivery Curr Cancer Drug Targets 10 2010 242 267
65. M. Hingorani, C.L. White, S. Zaidi, H.S. Pandha, A.A. Melcher, and S.A. Bhide Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair Mol Ther 18 2010 1599 1605
66. A.L. Ho, R. Grewal, R. Leboeuf, E. Sherman, M. Fury, and D. Pfister Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the selective MEK inhibitor selumetinib Thyroid 21 S1 2011 A-111
67. P. Hou, E. Bojdani, and M. Xing Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways J Clin Endocrinol Metab 95 2010 820 828
68. P.H. Hsyu, B. Bowen, and D. Tang-Liu Pharmacokinetics of a novel retinoid AGN 190168 and its metabolite AGN 190299 after intravenous administration of AGN 190168 to rats Biopharm Drug Dispos 15 1994 347 357
69. R. Huang, Z. Zhao, X. Ma, S. Li, R. Gong, and A. Kuang Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter Cancer Gene Ther 18 2011 144 152
70. N. Idres, J. Marill, M.A. Flexor, and G.G. Chabot Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers J Biol Chem 277 2002 31491 31498
71. Y.H. Jeon, Y. Choi, H.J. Kim, C.W. Kim, J.M. Jeong, and D.S. Lee Human sodium iodide symporter gene adjunctive radiotherapy to enhance the preventive effect of hMUC1 DNA vaccine Int J Cancer 121 2007 1593 1599
72. Y.H. Jeon, S.J. Ahn, Y.J. Lee, Y.L. Lee, S.W. Lee, and S.Y. Park Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer Cancer Biother Radiopharm 25 2010 671 679
73. Y.H. Jeon, H.W. Lee, Y.L. Lee, J.E. Kim, M.H. Hwang, and S.Y. Jeong Combined E7-dendritic cell-based immunotherapy and human sodium/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer Cancer Biother Radiopharm 26 2011 671 679
74. Y. Jiang, C. Chen, Z. Li, W. Guo, J.A. Gegner, and S. Lin Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta) J Biol Chem 271 1996 17920 17926
75. M. Josefsson, T. Grunditz, T. Ohlsson, and E. Ekblad Sodium/iodide- symporter: distribution in different mammals and role in entero-thyroid circulation of iodide Acta Physiol Scand 175 2002 129 137
76. M. Josefsson, L. Evilevitch, B. Westrom, T. Grunditz, and E. Ekblad Sodium-iodide symporter mediates iodide secretion in rat gastric mucosa in vitro Exp Biol Med (Maywood) 231 2006 277 281
77. K.H. Jung, J.Y. Paik, B.H. Ko, and K.H. Lee Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells J Nucl Med 49 2008 1966 1972
78. H. Kagechika Novel synthetic retinoids and separation of the pleiotropic retinoidal activities Curr Med Chem 9 2002 591 608
79. F. Kambe, Y. Nomura, T. Okamoto, and H. Seo Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells Mol Endocrinol 10 1996 801 812
80. A. Kawaguchi, M. Ikeda, T. Endo, T. Kogai, A. Miyazaki, and T. Onaya Transforming growth factor-beta1 suppresses thyrotropin-induced Na+/I- symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells Thyroid 7 1997 789 794
81. S.M. Keefe, M.A. Cohen, and M.S. Brose Targeting vascular endothelial growth factor receptor in thyroid cancer: the intracellular and extracellular implications Clin Cancer Res 16 2010 778 783
82. H.J. Kim, Y.H. Jeon, J.H. Kang, Y.J. Lee, K.I. Kim, and H.K. Chung In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter Cancer Biol Ther 6 2007 1130 1135
83. J.E. Kim, B.C. Ahn, M.H. Hwang, Y.H. Jeon, S.Y. Jeong, and S.W. Lee Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma J Nucl Med 52 2011 1756 1763
84. S.H. Kim, H.K. Chung, J.H. Kang, K.I. Kim, Y.H. Jeon, and Y.N. Jin Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter Hum Gene Ther 19 2008 951 957
85. S. Kim, H. Youn, M.G. Song, J.H. Kang, H.K. Chung, and D.S. Lee Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy Cancer Gene Ther 19 2012 263 270
86. M. Kitazono, R. Robey, Z. Zhan, N.J. Sarlis, M.C. Skarulis, and T. Aikou Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells J Clin Endocrinol Metab 86 2001 3430 3435
87. K. Klutz, V. Russ, M.J. Willhauck, N. Wunderlich, C. Zach, and F.J. Gildehaus Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene Clin Cancer Res 15 2009 6079 6086
88. K. Klutz, M.J. Willhauck, C. Dohmen, N. Wunderlich, K. Knoop, and C. Zach Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene Hum Gene Ther 22 2011 1563 1574
89. K. Knoop, M. Kolokythas, K. Klutz, M.J. Willhauck, N. Wunderlich, and D. Draganovici Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery Mol Ther 19 2011 1704 1713
90. K.A. Knostman, J.A. McCubrey, C.D. Morrison, Z. Zhang, C.C. Capen, and S.M. Jhiang PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer BMC Cancer 7 2007 137
91. T. Kogai, T. Endo, T. Saito, A. Miyazaki, A. Kawaguchi, and T. Onaya Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells Endocrinology 138 1997 2227 2232
92. T. Kogai, F. Curcio, S. Hyman, E.M. Cornford, G.A. Brent, and J.M. Hershman Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression J Endocrinol 167 2000 125 135
93. T. Kogai, J.J. Schultz, L.S. Johnson, M. Huang, and G.A. Brent Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line Proc Natl Acad Sci U S A 97 2000 8519 8524
94. T. Kogai, J.M. Hershman, K. Motomura, T. Endo, T. Onaya, and G.A. Brent Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells Endocrinology 142 2001 3369 3379
95. T. Kogai, Y. Kanamoto, L.H. Che, K. Taki, F. Moatamed, and J.J. Schultz Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models Cancer Res 64 2004 415 422
96. T. Kogai, Y. Kanamoto, A.I. Li, L.H. Che, E. Ohashi, and K. Taki Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells Endocrinology 146 2005 3059 3069
97. T. Kogai, K. Taki, and G.A. Brent Enhancement of sodium/iodide symporter expression in thyroid and breast cancer Endocr Relat Cancer 13 2006 797 826
98. T. Kogai, E. Ohashi, M.S. Jacobs, S. Sajid-Crockett, M.L. Fisher, and Y. Kanamoto Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/ phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways J Clin Endocrinol Metab 93 2008 1884 1892
99. T. Kogai, S. Sajid-Crockett, L.S. Newmarch, Y.Y. Liu, and G.A. Brent Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells J Endocrinol 199 2008 243 252
100. T. Kogai, Y.Y. Liu, K. Mody, D.V. Shamsian, and G.A. Brent Regulation of sodium iodide symporter gene expression by the Rac1/p38beta MAP kinase signaling pathway in MCF-7 breast cancer cells J Biol Chem 287 2012 3292 3300
101. M. Lacroix, and G. Leclercq Relevance of breast cancer cell lines as models for breast tumours: an update Breast Cancer Res Treat 83 2004 249 289
102. P.W. Ladenson, L.E. Braverman, E.L. Mazzaferri, F. Brucker-Davis, D.S. Cooper, and J.R. Garber Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma N Engl J Med 337 1997 888 896
103. D. Laperriere, T.T. Wang, J.H. White, and S. Mader Widespread Alu repeat-driven expansion of consensus DR2 retinoic acid response elements during primate evolution BMC Genomics 8 2007 23
104. O. Levy, A. De la Vieja, C.S. Ginter, C. Riedel, G. Dai, and N. Carrasco N-linked glycosylation of the thyroid Na+/I- symporter (NIS). Implications for its secondary structure model J Biol Chem 273 1998 22657 22663
105. H. Li, K.W. Peng, D. Dingli, R.A. Kratzke, and S.J. Russell Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy Cancer Gene Ther 17 2010 550 558
106. C.Y. Lin, T. Gurlo, L. Haataja, W.A. Hsueh, and P.C. Butler Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway J Clin Endocrinol Metab 90 2005 6678 6686
107. P.M. Majerus, and P.A. Courtois Susceptibility of Candida albicans to peroxidase-catalyzed oxidation products of thiocyanate, iodide and bromide J Biol Buccale 20 1992 241 245
108. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, and K. Umesono The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
109. D. Mannavola, P. Coco, G. Vannucchi, R. Bertuelli, M. Carletto, and P.G. Casali A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake J Clin Endocrinol Metab 92 2007 3531 3534
110. A. Mansouri, K. Chowdhury, and P. Gruss Follicular cells of the thyroid gland require Pax8 gene function Nat Genet 19 1998 87 90
111. J. Maruca, S. Santner, K. Miller, and R.J. Santen Prolonged iodine clearance with a depletion regimen for thyroid carcinoma: concise communication J Nucl Med 25 1984 1089 1093
112. S. Masia, S. Alvarez, A.R. de Lera, and D. Barettino Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor Mol Endocrinol 21 2007 2391 2402
113. H.R. Maxon, and H.S. Smith Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer Endocrinol Metab Clin North Am 19 1990 685 718
114. H.R. Maxon, S.R. Thomas, V.S. Hertzberg, J.G. Kereiakes, I.W. Chen, and M.I. Sperling Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer N Engl J Med 309 1983 937 941
115. R.D. Medh, and T.J. Schmidt Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells J Steroid Biochem Mol Biol 62 1997 129 142
116. C.A. Meier, L.E. Braverman, S.A. Ebner, I. Veronikis, G.H. Daniels, and D.S. Ross Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study) J Clin Endocrinol Metab 78 1994 188 196
117. C. Menzel, W.T. Kranert, N. Dobert, M. Diehl, T. Fietz, and N. Hamscho rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I J Nucl Med 44 2003 1065 1068
118. J.K. Miller, E.W. Swanson, and G.E. Spalding Iodine absorption, excretion, recycling, and tissue distribution in the dairy cow J Dairy Sci 58 1975 1578 1593
119. MIRD Summary of current radiation dose estimates to humans from 123I, 124I, 125I, 126I, 130I, 131I, and 132I as sodium iodide J Nucl Med 16 1975 857 860
120. N. Mitsutake, M. Miyagishi, S. Mitsutake, N. Akeno, C. Mesa Jr., and J.A. Knauf BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis Endocrinology 147 2006 1014 1019
121. Y. Mizukami, T. Hashimoto, A. Nonomura, T. Michigishi, S. Nakamura, and M. Noguchi Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein J Clin Endocrinol Metab 79 1994 616 619
122. C.A. Montiel-Equihua, P. Martin-Duque, A. de la Vieja, M. Quintanilla, J. Burnet, and G. Vassaux Targeting sodium/iodide symporter gene expression for estrogen-regulated imaging and therapy in breast cancer Cancer Gene Ther 15 2008 465 473
123. D.H. Moon, S.J. Lee, K.Y. Park, K.K. Park, S.H. Ahn, and M.S. Pai Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues Nucl Med Biol 28 2001 829 834
124. S. Nagpal, and R.A. Chandraratna Recent developments in receptor-selective retinoids Curr Pharm Des 6 2000 919 931
125. J.P. Nicola, C. Basquin, C. Portulano, A. Reyna-Neyra, M. Paroder, and N. Carrasco The Na+/I- symporter mediates active iodide uptake in the intestine Am J Physiol Cell Physiol 296 2009 C654 C662
126. J.P. Nicola, M.L. Velez, A.M. Lucero, L. Fozzatti, C.G. Pellizas, and A.M. Masini-Repiso Functional toll-like receptor 4 conferring lipopolysaccharide responsiveness is expressed in thyroid cells Endocrinology 150 2009 500 508
127. J.P. Nicola, M. Nazar, I.D. Mascanfroni, C.G. Pellizas, and A.M. Masini-Repiso NF-kappaB p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8 Mol Endocrinol 24 2010 1846 1862
128. M.M. Norden, F. Larsson, S. Tedelind, T. Carlsson, C. Lundh, and E. Forssell-Aronsson Down-regulation of the sodium/iodide symporter explains 131I-induced thyroid stunning Cancer Res 67 2007 7512 7517
129. E. Ohashi, T. Kogai, H. Kagechika, and G.A. Brent Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells Cancer Res 69 2009 3443 3450
130. M. Ohno, M. Zannini, O. Levy, N. Carrasco, and R. di Lauro The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription Mol Cell Biol 19 1999 2051 2060
131. K. Ohta, T. Endo, and T. Onaya The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues Biochem Biophys Res Commun 174 1991 1148 1153
132. K. Ohta, X.P. Pang, L. Berg, and J.M. Hershman Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor J Clin Endocrinol Metab 82 1997 2633 2638
133. H. Ohye, and M. Sugawara Dual oxidase, hydrogen peroxide and thyroid diseases Exp Biol Med (Maywood) 235 2010 424 433
134. X.P. Pang, M. Park, and J.M. Hershman Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells Endocrinology 131 1992 45 50
135. J.W. Park, R. Zarnegar, H. Kanauchi, M.G. Wong, W.C. Hyun, and D.G. Ginzinger Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines Thyroid 15 2005 222 231
136. I. Peerlinck, A. Merron, P. Baril, S. Conchon, P. Martin-Duque, and C. Hindorf Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter Clin Cancer Res 15 2009 6595 6601
137. L. Pei, and S. Melmed Isolation and characterization of a pituitary tumor-transforming gene (PTTG) Mol Endocrinol 11 1997 433 441
138. A.E. Pekary, and J.M. Hershman Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I- symporter messenger ribonucleic acid levels in FRTL-5 cells Endocrinology 139 1998 703 712
139. L. Pesce, A. Bizhanova, J.C. Caraballo, W. Westphal, M.L. Butti, and A. Comellas TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells Endocrinology 153 2012 512 521
140. M.A. Pisarev, L. Thomasz, and G.J. Juvenal Role of transforming growth factor beta in the regulation of thyroid function and growth Thyroid 19 2009 881 892
141. M. Pomerance, H.B. Abdullah, S. Kamerji, C. Correze, and J.P. Blondeau Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, rac1, and reactive oxygen species J Biol Chem 275 2000 40539 40546
142. R. Pramanik, X. Qi, S. Borowicz, D. Choubey, R.M. Schultz, and J. Han p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity J Biol Chem 278 2003 4831 4839
143. F. Puglisi, D. Cesselli, G. Damante, L. Pellizzari, C.A. Beltrami, and C. Di Loreto Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases Anticancer Res 20 2000 311 316
144. C. Puppin, F. Arturi, E. Ferretti, D. Russo, R. Sacco, and G. Tell Transcriptional regulation of human sodium/iodide symporter gene: a role for redox factor-1 Endocrinology 145 2004 1290 1293
145. M.L. Read, G.D. Lewy, J.C. Fong, N. Sharma, R.I. Seed, and V.E. Smith Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment Cancer Res 71 2011 6153 6164
146. J.C. Ricarte-Filho, M. Ryder, D.A. Chitale, M. Rivera, A. Heguy, and M. Ladanyi Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1 Cancer Res 69 2009 4885 4893
147. C. Riedel, O. Levy, and N. Carrasco Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin J Biol Chem 276 2001 21458 21463
148. G. Riesco-Eizaguirre, and P. Santisteban A perspective view of sodium iodide symporter research and its clinical implications Eur J Endocrinol 155 2006 495 512
149. G. Riesco-Eizaguirre, I. Rodriguez, A. De la Vieja, E. Costamagna, N. Carrasco, and M. Nistal The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer Cancer Res 69 2009 8317 8325
150. G. Riesco-Eizaguirre, A. De la Vieja, I. Rodriguez, S. Miranda, P. Martin-Duque, and G. Vassaux Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach J Clin Endocrinol Metab 96 2011 E1435 E1443
151. D.S. Riggs Quantitative aspects of iodine metabolism in man Pharmacol Rev 4 1952 284 370
152. C. Saez, M.A. Martinez-Brocca, C. Castilla, A. Soto, E. Navarro, and M. Tortolero Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer J Clin Endocrinol Metab 91 2006 1404 1409
153. T. Saito, T. Endo, A. Kawaguchi, M. Ikeda, M. Nakazato, and T. Kogai Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue J Clin Endocrinol Metab 82 1997 3331 3336
154. T. Saito, T. Endo, A. Kawaguchi, M. Ikeda, R. Katoh, and A. Kawaoi Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas J Clin Invest 101 1998 1296 1300
155. M. Saji, and L.D. Kohn Effect of hydrocortisone on the ability of thyrotropin to increase deoxyribonucleic acid synthesis and iodide uptake in FRTL-5 rat thyroid cells: opposite regulation of adenosine 3′,5′- monophosphate signal action Endocrinology 127 1990 1867 1876
156. M. Saji, and L.D. Kohn Insulin and insulin-like growth factor-I inhibit thyrotropin-increased iodide transport in serum-depleted FRTL-5 rat thyroid cells: modulation of adenosine 3′,5′-monophosphate signal action Endocrinology 128 1991 1136 1143
157. A.K. Salem, M.S. Fenton, K.M. Marion, and J.M. Hershman Effect of sunitinib on growth and function of FRTL-5 thyroid cells Thyroid 18 2008 631 635
158. A.M. Sawka, K. Thephamongkhol, M. Brouwers, L. Thabane, G. Browman, and H.C. Gerstein Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer J Clin Endocrinol Metab 89 2004 3668 3676
159. M. Schlumberger Papillary and follicular thyroid carcinoma N Engl J Med 338 1998 297 306
160. M. Schlumberger, L. Lacroix, D. Russo, S. Filetti, and J.M. Bidart Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients Nat Clin Pract Endocrinol Metab 3 2007 260 269
161. C. Schmutzler, and J. Kohrle Retinoic acid redifferentiation therapy for thyroid cancer Thyroid 10 2000 393 406
162. C. Schmutzler, R. Winzer, J. Meissner-Weigl, and J. Kohrle Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells Biochem Biophys Res Commun 240 1997 832 838
163. R.E. Schweppe, J.P. Klopper, C. Korch, U. Pugazhenthi, M. Benezra, and J.A. Knauf Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification J Clin Endocrinol Metab 93 2008 4331 4341
164. H. Sebai, S. Hovsepian, E. Ristorcelli, E. Aouani, D. Lombardo, and G. Fayet Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5 Thyroid 20 2010 195 203
165. K. Seibert, S.M. Shafie, T.J. Triche, J.J. Whang-Peng, S.J. O'Brien, and J.H. Toney Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice Cancer Res 43 1983 2223 2239
166. R.D. Semba, and F. Delange Iodine in human milk: perspectives for infant health Nutr Rev 59 2001 269 278
167. D.H. Shen, D.K. Marsee, J. Schaap, W. Yang, J.Y. Cho, and G. Hinkle Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy Gene Ther 11 2004 161 169
168. H. Shimura, K. Haraguchi, A. Miyazaki, T. Endo, and T. Onaya Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene Endocrinology 138 1997 4493 4496
169. M. Shinohara, Y.J. Chung, M. Saji, and M.D. Ringel AKT in thyroid tumorigenesis and progression Endocrinology 148 2007 942 947
170. P.A. Smanik, K.Y. Ryu, K.S. Theil, E.L. Mazzaferri, and S.M. Jhiang Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter Endocrinology 138 1997 3555 3558
171. V.E. Smith, M.L. Read, A.S. Turnell, R.J. Watkins, J.C. Watkinson, and G.D. Lewy A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer J Cell Sci 122 2009 3393 3402
172. C. Spitzweg, M.K. O'Connor, E.R. Bergert, D.J. Tindall, C.Y. Young, and J.C. Morris Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter Cancer Res 60 2000 6526 6530
173. C. Spitzweg, A.B. Dietz, M.K. O'Connor, E.R. Bergert, D.J. Tindall, and C.Y. Young In vivo sodium iodide symporter gene therapy of prostate cancer Gene Ther 8 2001 1524 1531
174. C. Spitzweg, C.H. Baker, E.R. Bergert, M.K. O'Connor, and J.C. Morris Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression Hum Gene Ther 18 2007 916 924
175. M. Sponziello, A. Scipioni, C. Durante, A. Verrienti, M. Maranghi, and L. Giacomelli Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines J Endocrinol Invest 33 2010 2 6
176. A.L. Stratford, K. Boelaert, L.A. Tannahill, D.S. Kim, A. Warfield, and M.C. Eggo Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis J Clin Endocrinol Metab 90 2005 4341 4349
177. J. Takamatsu, T. Hosoya, M. Tsuji, M. Yamada, Y. Murakami, and S. Sakane Peroxidase and coupling activities of thyroid peroxidase in benign and malignant thyroid tumor tissues Thyroid 2 1992 193 196
178. K. Taki, T. Kogai, Y. Kanamoto, J.M. Hershman, and G.A. Brent A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3′,5′-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells Mol Endocrinol 16 2002 2266 2282
179. S. Tanosaki, T. Ikezoe, A. Heaney, J.W. Said, K. Dan, and M. Akashi Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells Breast Cancer Res Treat 79 2003 335 345
180. U.H. Tazebay, I.L. Wapnir, O. Levy, O. Dohan, L.S. Zuckier, and Q.H. Zhao The mammary gland iodide transporter is expressed during lactation and in breast cancer Nat Med 6 2000 871 878
181. G. Tell, L. Pellizzari, D. Cimarosti, C. Pucillo, and G. Damante Ref-1 controls pax-8 DNA-binding activity Biochem Biophys Res Commun 252 1998 178 183
182. M.W. Titcomb, M.M. Gottardis, J.W. Pike, and E.A. Allegretto Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extracts Mol Endocrinol 8 1994 870 877
183. Y. Tong, and T. Eigler Transcriptional targets for pituitary tumor-transforming gene-1 J Mol Endocrinol 43 2009 179 185
184. F. Trapasso, R. Iuliano, E. Chiefari, F. Arturi, A. Stella, and S. Filetti Iodide symporter gene expression in normal and transformed rat thyroid cells Eur J Endocrinol 140 1999 447 451
185. M.A. Trujillo, M.J. Oneal, S. McDonough, R. Qin, and J.C. Morris A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer Gene Ther 17 2010 1325 1332
186. L.C. Tsai, M.W. Hung, Y.H. Chen, W.C. Su, G.G. Chang, and T.C. Chang Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells Eur J Biochem 267 2000 1330 1339
187. S. Unterholzner, M.J. Willhauck, N. Cengic, M. Schutz, B. Goke, and J.C. Morris Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells J Clin Endocrinol Metab 91 2006 69 78
188. D.D. Vadysirisack, A. Venkateswaran, Z. Zhang, and S.M. Jhiang MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner Endocr Relat Cancer 14 2007 421 432
189. L. Valenta Metastatic thyroid carcinoma in man concentrating iodine without organification J Clin Endocrinol Metab 26 1966 1317 1324
190. D. Van Nostrand The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer Thyroid 19 2009 1381 1391
191. A. Venkateswaran, D.K. Marsee, S.H. Green, and S.M. Jhiang Forskolin, 8-Br-3′,5′-cyclic adenosine 5′-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium/iodide symporter protein levels in RET/PTC1-expressing cells J Clin Endocrinol Metab 89 2004 6168 6172
192. M. Volante, I. Rapa, M. Gandhi, G. Bussolati, D. Giachino, and M. Papotti RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact J Clin Endocrinol Metab 94 2009 4735 4741
193. E.F. Wagner, and A.R. Nebreda Signal integration by JNK and p38 MAPK pathways in cancer development Nat Rev Cancer 9 2009 537 549
194. I.L. Wapnir, M. van de Rijn, K. Nowels, P.S. Amenta, K. Walton, and K. Montgomery Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections J Clin Endocrinol Metab 88 2003 1880 1888
195. I.L. Wapnir, M. Goris, A. Yudd, O. Dohan, D. Adelman, and K. Nowels The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid Clin Cancer Res 10 2004 4294 4302
196. L.S. Ward, P.L. Santarosa, F. Granja, L.V. da Assumpcao, M. Savoldi, and G.H. Goldman Low expression of sodium iodide symporter identifies aggressive thyroid tumors Cancer Lett 200 2003 85 91
197. R.P. Warrell Jr. Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications Blood 82 1993 1949 1953
198. R.J. Watkins, M.L. Read, V.E. Smith, N. Sharma, G.M. Reynolds, and L. Buckley Pituitary tumor transforming gene binding factor: a new gene in breast cancer Cancer Res 70 2010 3739 3749
199. S. Wei, J. Yang, S.L. Lee, S.K. Kulp, and C.S. Chen PPARgamma-independent antitumor effects of thiazolidinediones Cancer Lett 276 2009 119 124
200. S.J. Weiss, N.J. Philp, and E.F. Grollman Iodide transport in a continuous line of cultured cells from rat thyroid Endocrinology 114 1984 1090 1098
201. P.L. Welcsh, and D.A. Mankoff Taking up iodide in breast tissue Nature 406 2000 688 689
202. M.J. Willhauck, B.R. Sharif Samani, K. Klutz, N. Cengic, I. Wolf, and L. Mohr Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma Gene Ther 15 2008 214 223
203. M.J. Willhauck, B. Sharif-Samani, R. Senekowitsch-Schmidtke, N. Wunderlich, B. Goke, and J.C. Morris Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone Breast Cancer Res Treat 109 2008 263 272
204. M.J. Willhauck, DJ, O. K., N. Wunderlich, B. Goke, and C. Spitzweg Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of (1)(3)(1)I by carbamazepine in breast cancer cells Breast Cancer Res Treat 125 2011 377 386
205. J. Wolff, J. Robbins, and J.E. Rall Iodide trapping without organification in a transplantable rat thyroid tumor Endocrinology 64 1959 1 11
206. K. Yamazaki, K. Suzuki, E. Yamada, T. Yamada, F. Takeshita, and M. Matsumoto Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded ribonucleic acid in cultured human thyroid follicles Endocrinology 148 2007 3226 3235
207. P.M. Yen Physiological and molecular basis of thyroid hormone action Physiol Rev 81 2001 1097 1142
208. J.K. Yoon, B.N. Park, J.Y. Paik, K.H. Jung, B.H. Ko, and K.H. Lee Effects of theophylline on radioiodide uptake in MCF-7 breast cancer and NIS gene-transduced SNU-C5 colon cancer cells Cancer Biother Radiopharm 24 2009 201 208